Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011
Silent Infarcts in Children With Sickle Cell Anemia and Abnormal Cerebral Artery Velocity
Arch Neurol 58:2017-2021, Pegelow,C.H.,et al, 2001
Prevent of a 1st Stroke by Transfusions in Children/Sickle Cell Anemia & Abnorm Results on Transcr Doppler Ultrasonog
NEJM 339:5-11, Adams,R.J.,et al, 1998
A 25-Year-Old Woman With Eye Swelling and HEadache
Neurol 100:879-883, Hehir,A.,et al, 2023
Contemporary Trends in the Nationwide Incidence of Primary Intracerebral Hemorrhage
Stroke 53:e70-e74, Bako, A.T.,et al, 2022
Vaccine-Induced Thrombocytopenia with Severe Headache
NEJM 385:doi:10.1056/NEJMc2112974, Salih, F.,et al, 2021
Diagnosis and Management of Active Intracranial Atherosclerotic Disease
Stroke 49:e221-e223, Narwal, P.,et al, 2018
Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke?
BMJ 362:k2515, Kuijpers, T.,et al, 2018
Pregnancy, Hormonal Treatments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke
Stroke 48:501-506, Caso, V.,et al, 2017
Community Based Case-Control Study of Childhood Stroke Risk Associated with Congenital Heart Disease
Stroke 46:336-340, Fox, C.K.,et al, 2015
Prevention Opportunities for Oral Contraceptive-Associated Ischemic Stroke
Stroke 45:893-895, Ryan, K.A.,et al, 2014
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
NEJM 371:699-710, DeBaun, M.R.,et al, 2014
Stroke Recurrence in Children with Congenital Heart Disease
Ann Neurol 72:103-111, Rodan, L.,et al, 2012
Association Between Recent Sports Activity, Sports Activity in Young Adulthood, and Stroke
Stroke 40:425-431, Grau,A.J.,et al, 2009
Treatment of Childhood Arterial Ischemic Stroke
Ann Neurol 63:679-696, Bernard,T.J.,et al, 2008
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Preeclampsia and the Risk of Ischemic Stroke Among Young Women
Stroke 37:1055-1059, Brown,D.W.,et al, 2006
Role of COL4A1 in Small-Vessel Disease and Hemorrhagic Stroke
NEJM 354:1489-1496, Gould,D.B.,et al, 2006
Major Risk Factors for Intracerebral Hemorrhage in the Young Are Modifiable
Stroke 36:1881-1885, Feldmann,E.,et al, 2005
Discontinuing Prophylactic Transfusions Used to Preven Stroke in Sickle Cell Disease
NEJM 353:2769-2778,2743, The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators, 2005
Moyamoya Syndrome Associated with Down Syndrome:Outcome After Surgical Revascularization
Pediatrics 116:e694-e701, Jea,A.,et al, 2005
Should Asymptomatic Patients with Hereditary Haemorrhagic Telangiectasia (HHT) be Screened for Cerebral Vascular Malformations? Data from 22 061 years of HHT Patient Life
JNNP 74:743-748, Easey,A.J.,et al, 2003
Major Risk Factors for Aneurysmal Subarrachnoid Hemorrhage in the Young are Modifiable
Stroke 34:1375-1381, Broderick,J.P.,et al, 2003
Improved Cerebrovascular Patency Following Therapy in Patients with Sickle Cell Disease: Initial Results in 4 Patients Who Received HLA-Identical Hematopoietic Stem Cell Allografts
Ann Neurol 49:222-229, Steen,R.G.,et al, 2001
Stroke Prevention and Treatment in Sickle Cell Disease
Arch Neurol 58:565-568, Adams,R.J., 2001
Cerebral Sinovenous Thrombosis in Children
NEJM 345:417-423, DeVeber,G.,et al, 2001
Surgical Closure of Patent Foramen Ovale in Cryptogenic Stroke Patients
Stroke 28:2376-2381, Homma,S.,et al, 1997
Discontinuation of Long-Term Transfusion Therapy in Patients with Sickle Cell Disease & Stroke
J Pediatr 131:757-760, Rana,S.,et al, 1997
Long-Term Stroke Risk in Children with Sickle Cell Disease Screened with Transcranial Doppler
Ann Neurol 42:699-704, Adams,R.J.,et al, 1997
Prognosis After Stroke Followed by Surgical Closure of Patent Foramen Ovale
Neurol 47:1162-1166, Devuyst,G.,et al, 1996
Routine Indomethacin Prophylaxis:Has the Time Come
Pediatrics 98:784-785, Bada,H.S., 1996
Risk of Recurrent Stroke in Patients with Sickle Cell Disease Treated with Erythrocyte Transfusions
J Pediatr 126:896-899, Pegelow,C.H.,et al, 1995
Low-Dose Indomethacin and Prevention of Intraventricular Hemorrhage:A Multicenter Randomized Trial
Pediatrics 93:543-550, 643, 677994., Ment,L.R.,et al, 1994
A Prospective Study of Cerebral Ischemia in the Young, Analysis of Pathogenic Determinants
Stroke 24:362-367, Carolei,A.,et al, 1993
Carotid Endarterectomy with Transcranial Doppler and Electroencephalographic Monitoring in 130 Operations
Stroke 24:665-669, Jansen,C.,et al, 1993
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
NEJM 326:605-610, 6371992., Adams,R.,et al, 1992
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
Familial Hyperlipidemia in Stroke in the Young
Stroke 17:1142-1145, Bansal,B.C.,et al, 1986
Submaxiomal Angioplasty for Severe Intracranial Atherosclerotic Stenosis":Benefit of Revascularization at Last
Stroke 56:e114-e118, Pensatok,U.,et al, 2025
Use and Eligibility for Glucose-Like Peptide-1 Receptor Agonist Treatment for Primary Preveention of Stroke
Neurol 104:e213739, Wilson,L.M. & Anderson,T.S., 2025
Left Atrial Appendage Occlusion and Its Role in Stroke Prevention
Stroke 56:1928-1937, Seiffge,D.J.,et al, 2025
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation
NEJM 392:2403-2412, 2473, Kharbanda,R.K.,et al, 2025
Collaboration on the Optimal Timing of Anticoagulation after Ischaemic Stroke and Atrial Fibrillation:A Systematic Review and Prospective Individual Participant Data Meta-Analysis of Randomised Controlled Trials (CATALYST)
Lancet 406:43-51, Dehbi,K-M.,et al, 2025
Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients with Atrial Fibrillation,A Systematic Review and Meta-Analysis
JAMA Neurol 82:696-705, McCabe,J.J.,et al, 2025
The Role of GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists in Primary Stroke Prevention
Stroke 56:e307-e309, Inikori,E.,et al, 2025
The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025
Anticoagulant Usage and Risk of Thromboembolic Events After Ischemic Stroke in Adults with Cancer
Neurol 105:e214325, Balali,P.,et al, 2025
Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024
Eye Toward Stroke Prevention:Central Retinal Artery Occlusion and Tandem Internal Carotid Artery Occlusion
Stroke 55:e165-e168, Cheronis,C.,et al, 2024